AstraZeneca is a international pharmaceutical and biological research company based in London. It is the 7th largest pharma company in the world and is also listed in the New York an OMX Swedish-Finnish stock exchanges.
AstraZeneca is the combination of the 1913 Astra AB company which was founded in Sweden by 400 doctors and apothecaries and the Zeneca Group which spun-off from ICI i 1993. The two companies merged in 1999 to form AstraZeneca.
AstraZeneca has formed many strategic alliances in the pharma sector including alliances with Bristol-Myers Squibb and Abbott Laboratories. In 2006 is acquired Cambridge Antibody Technology.
AstraZeneca employs around 11,000 people in the UK with 4,500 based in the Alderley Park research centre. Another 4,000 people are employed in Sweden.
AstraZeneca Key Products
AstraZeneca is a leader in researching and producing medicines in these areas:
- Cardiac and vascular
- Neurological and psychiatric
- Pathological inflammation
AstraZeneca is a private limited company registered in England and Wales under company number 03674842.
- 2 Kingdom Street
- LondonW2 6BD
- +44 (0)20 7604 8000
- Equiniti Limited
- Aspect House
- Spencer Road
- West Sussex
- BN99 6DA
- Tel: (in UK) 0800 389 1580
- Tel: (outside UK) +44 (0)121 415 7033
AstraZeneca Dividend Payments
Dividends are paid twice a year, with a greater proportion paid as a second interim. The first payment is made in September and the second in March.
View AstraZeneca dividend history here: www.astrazeneca.com/Investors/Investor-tools/Dividend-calculator